ALFA Finder| Management target | Revenue 15.0% FY27 |
|---|
| Revenue growth | Revenue rose 11.3% YoY to ₹165.6 Cr, primarily volume-led. |
|---|---|
| Margins | EBITDA margins improved 70 bps YoY to 17.8%. |
| Demand visibility | Strong demand in domestic API and upcoming specialized oncology/peptide segments. |
| Management confidence | Confident, focusing on transitioning to high-value science-led API modules. |
Growth
Revenue grew 11.3% YoY to ₹165.6 Cr, driven by a 27% surge in domestic API volumes.
Outlook
Management guides for 10-15% topline and profit growth in FY27, aiming for ₹1000 Cr revenue by FY29.
Risks
Prolonged high working capital cycles and inventory bunching due to geopolitical risk remain key concerns.
Earnings Call Transcript filed with NSE, NSE: BAJAJHCARE. Summary written with AI assistance from the document.
Bajaj Healthcare Ltd: key numbers
- Share price
- ₹325.35
- Market cap
- ₹1,095 Cr
- Revenue (annual)
- ₹611.0 Cr
- Net profit (annual)
- ₹15.77 Cr
- P/E (TTM)
- 53.1×Sector 43.8×
- Promoter holding
- 58.59%+0.00% QoQ
- FII holding
- 2.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bajaj Healthcare Ltd
All →Bajaj Healthcare Earnings Call Transcript: Key Takeaways
Bajaj Healthcare delivered strong H1 growth led by a 82% surge in formulations and key new specialty launches.
- Call
- Guides 15% growth
Bajaj Healthcare Results Update
Bajaj Healthcare reported Q2 FY27 revenue of ₹175.9 Crore, up 18.9% YoY. EBITDA stood at ₹32.1 Crore, reflecting a 12.2% YoY increase.
Bajaj Healthcare Other Announcement
Bajaj Healthcare filed its Monitoring Agency Report for the quarter ended September 30, 2026, as required by SEBI regulations for the utilization of preferential issue proceeds.
Bajaj Healthcare Q2 FY27 Results: Net Profit ₹14.1 Cr, Up 27.0% YoY
Bajaj Healthcare Ltd reported revenue from operations of ₹175.9 Cr (+18.9% YoY) and net profit of ₹14.1 Cr (+27.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹14.1 Cr · +27.0% YoY
Bajaj Healthcare Acquisition
Bajaj Healthcare received NCLT approval to acquire Genrx Pharmaceuticals Private Limited as a going concern. The entity will become a wholly owned subsidiary.
Bajaj Healthcare Merger & Restructuring Worth ₹14.67 Cr
Bajaj Healthcare Limited has executed a deed of assignment to sell its undertaking located in Dahej Industrial Area, Gujarat, for approximately Rs. 14.67 Crore.
- Value
- ₹14.67 Cr